血栓调节蛋白可完全抑制凝血酶和利斯托司汀诱导的血小板聚集。
Thrombomodulin can entirely inhibit thrombin and ristocetin-induced platelet aggregation.
目的评估疏血通对髋关节置换手术患者术后血栓调节蛋白（TM）的影响。
Objective To investigate the change of plasma thrombomudolin (PTM) in the patients after hip replacement receiving treatment of Shuxuetong complex.
目的研究血栓调节蛋白(TM)在肾盂移行细胞癌及肾细胞癌中的表达及临床意义。
Objective To study the expression of thrombomodulin (TM) in renal pelvic transitional cell carcinoma and in renal cell carcinoma.
目的研究二种恶性血液病白血病和骨髓瘤患者血浆血栓调节蛋白 （PTM）的水平及临床意义。
Objective To study clinical significance and levels of plasma thromobomodulin (PTM)in two kind of malignant hematological diseases leukemia and myloma.
前言： 目的：探讨血栓调节蛋白（TM）在多器官功能障碍综合征（M ODS）中的表达及其意义。
Objective:To study the expression of thrombomodulin(TM) and its significance in the pathogenesis of multiple organs dysfunction syndrome(MODS).
本文对29例急性非淋巴细胞白血病(ANLL)患者的血浆血栓调节蛋白(TM)水平进行检测，发现ANLL组血浆TM水平比正常组明显升高。
The plasma concentration of thrombomodulin (TM) were measured in 29 cases of acute non-lymphocytic leukemia (ANLL). Plasma TM level significantly increased in ANLL patients.
有关APC的最新资料表明，它对调节血栓形成、纤维蛋白溶解和炎症反应均有重要作用。
New information related to APC suggests that it may be the critical link in achieving the regulation of thrombosis, fibrinolysis, and inflammation.
有关APC的最新资料表明，它对调节血栓形成、纤维蛋白溶解和炎症反应均有重要作用。
New information related to APC suggests that it may be the critical link in achieving the regulation of thrombosis, fibrinolysis, and inflammation.
应用推荐